The prophylactic use of botulinum toxin A in patients with chronic migraine may reduce the total cost of acute migraine medications

Author:  

Publisher: Adis International

ISSN: 1173-5503

Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.557, 2008-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract